MedTrace Logo

ILM Peeling in PDR Patients Undergoing PPV for VH

NCT03660371 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 258

Last updated 2021-12-02

No results posted yet for this study

Summary

Subjects undergoing ILM peeling during vitrectomy will have better visual acuity and lower rates of DME to control subjects

Conditions

Interventions

PROCEDURE

PPV/MP

Internal limiting membrane (ILM) peeling during vitrectomy for the indication of diabetic vitreous hemorrhaging

PROCEDURE

PPV without MP

No internal limiting membrane (ILM) peeling during vitrectomy for the indication of diabetic vitreous hemorrhaging

Sponsors & Collaborators

  • Rush Eye Associates

    lead OTHER

Principal Investigators

  • Sloan Rush · panhandle eye group

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-04
Primary Completion
2020-03-04
Completion
2020-03-04

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03660371 on ClinicalTrials.gov